Karen A. Moser

Karen A. Moser, MD

Languages spoken: English, French

  • Dr. Moser is an associate professor of pathology at the University of Utah School of Medicine. She received her M.D. from Saint Louis University and subsequently served as a pathology resident and hematopathology fellow at the University of Utah School of Medicine. She is certified by the American Board of Pathology in anatomic and clinical pathology, with subspecialty certification in hematology. Dr. Moser is a member of several professional societies, including the College of American Pathologists, American Society for Clinical Pathology, and International Society on Thrombosis and Haemostasis, and currently serves as the Vice-Chair for the Clinical and Laboratory Standards Institute (CLSI) Expert Panel on Hematology, Immunology, and Ligand Assays. Her primary research interests are in laboratory hemostasis and thrombosis testing and pathology education.

    Specialties

    Board Certification

    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Hematology)

  • Dr. Moser is an associate professor of pathology at the University of Utah School of Medicine. She received her M.D. from Saint Louis University and subsequently served as a pathology resident and hematopathology fellow at the University of Utah School of Medicine. She is certified by the American Board of Pathology in anatomic and clinical pathology, with subspecialty certification in hematology. Dr. Moser is a member of several professional societies, including the College of American Pathologists, American Society for Clinical Pathology, and International Society on Thrombosis and Haemostasis, and currently serves as the Vice-Chair for the Clinical and Laboratory Standards Institute (CLSI) Expert Panel on Hematology, Immunology, and Ligand Assays. Her primary research interests are in laboratory hemostasis and thrombosis testing and pathology education.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Hematology)

    Education history

    Fellowship Hematopathology - University of Utah School of Medicine Fellow
    Pathology - University of Utah School of Medicine Co-Chief Resident
    Residency Anatomic and Clinical Pathology - University of Utah School of Medicine Resident
    Medicine - Saint Louis University School of Medicine M.D.
    Undergraduate French - Saint Louis University B.A.
    Undergraduate Biology - Saint Louis University B.S.

    Selected Publications

    Journal Article

    1. Pearson L, Moser KA, Schmidt RL (2020). D-dimer varies widely across instrument platforms and is not a reliable indicator of periprosthetic joint infections. Arthroplast Today, 6(4), 686-688.
    2. Dinarvand P, Moser K (2019). Protein C Deficiency. Arch Pathol Lab Med, 143(10), 1281-1285.
    3. Smock KJ, Moser KA (05/2019). What have we learned from coagulation laboratory participation in external quality programs? Int J Lab Hematol, 41(Suppl 1), 49-55.
    4. Chandler WL, Brown AF, Chen D, Moser K, Olson JD, Pham HP, Smock KJ, Volod O, Higgins RA (12/21/2018). External quality assurance of platelet function assays: Results of the College of American Pathologists Proficiency Testing Program. Arch Pathol Lab Med, 143(4), 472-482.
    5. Ravulapati S, Leung C, Maughan ST, Moser K, Batanian J, Poddar N (2016). A unique case of Epstein-Barr virus related hemophagocytic lymphohistiocytosis with very complex cytogenetics in an adult male. Ann Hematol Oncol, 3(8), 1109.
    6. Moser KA, Puetz J (2015). Challenging hemostasis scenarios in pediatric patients--two case studies. Int J Lab Hematol, 37 Suppl 1, 72-7. (Read full article)
    7. Moser KA, Adcock Funk DM (2014). Chromogenic factor VIII activity assay. Am J Hematol, 89(7), 781-4. (Read full article)
    8. Moser KA, Adcock Funk DM (2013). Pitfalls in special coagulation testing: three illustrative case studies. Int J Lab Hematol, 35(3), 334-8. (Read full article)
    9. Neri C, Moser K, Pysher TJ, Boettger DR, Neri G, Opitz JM (2011). The FG syndrome from a pathological perspective. Fetal Pediatr Pathol, 30(2), 71-6. (Read full article)
    10. Comstock J, Bruggers C, Moser K, Hedlund G, Chin S, Riva-Cambrin J, Zhou H (2009). Leptomeningeal melanoma with foci of rhabdomyosarcoma in an infant with giant congenital nevi: a case report and literature review. Pathol Case Rev, 14(3), 100-03.

    Book Chapter

    1. Moser KA (02/01/2019). EDTA plasma mimicking combined FV and FVIII deficiency. In Gulati G, Filicko-O’Hara J, Krause J (Eds.), ASCP CaseSet: Case Studies in Hematology and Coagulation (2nd Edition). Chicago, IL: ASCP Press.
    2. Moser KA, Patel N (02/01/2019). Trousseau syndrome. In Gulati G, Filicko-O’Hara J, Krause J (Eds.), ASCP CaseSet: Case Studies in Hematology and Coagulation (2nd Edition). Chicago,IL: ASCP Press.
    3. Smith MD, Moser KA (2016). Heparin-Induced Thrombocytopenia. In Kottke-Marchant K (Ed.), An Algorithmic Approach to Hemostasis Testing (2nd Edition, pp. 317-26). Northfield, IL: CAP Press.
    4. Adcock DM, Moser KA, Chen D (2016). Thrombotic Microangiopathies. In Kottke-Marchant K (Ed.), An Algorithmic Approach to Hemostasis Testing (2nd Edition, pp. 337-56). Northfield, IL: CAP Press.
    5. Moser KA (2016). Overview of Antithrombotic Agents. In Kottke-Marchant K (Ed.), An Algorithmic Approach to Hemostasis Testing (2nd Edition, pp. 373-8). Northfield, IL: CAP Press.

    Case Report

    1. Abou-Ismail MY, Moser KA, Smock KJ, Lim MY (2021). Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism. Am J Hematol, 96(9), E346-E349. (Read full article)
    2. Moser KA, George TI, Karner KH (2020). Unexpected diagnosis of indolent systemic mastocytosis through evaluation of next generation sequencing data. Web, 20, 38-39.

    Editorial

    1. Moser KA (2019). D-dimer: Common Assay, Challenges Abound, Caution Advised. J Appl Lab Med, 3(5), 756-759.

    Letter

    1. Moser KA, Pearson L, Pelt CE, Olson JD, Goodwin AJ, Isom JA, Harris NS, Pham HP, Smock KJ, Unold D, VanSandt AM, Volod O, Chen D (2020). Letter to the Editor regarding "The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence Based and Validated Criteria." [Letter to the editor]. J Arthroplasty, 35(9), 2682-2693..

    Abstract

    1. Moser K, Bovio I, Hill S, Tripp SR, Perkins SL, Bahler DW (2012). Improved identification of megakaryoblasts by flow cytometry relative to immunohistochemistry; also presented at United States and Canadian Academy of Pathology Annual Meeting, Vancouver, BC, Canada [Abstract]. Mod Pathol, 25(suppl 2), 356A.
    2. Moser K, Salama ME, Kohan JL, Tripp SR, Bahler DW, Perkins SL (2012). Flow cytometry versus immunoperoxidase staining for determination of plasma cell clonality with small plasma cell numbers; also presented at United States and Canadian Academy of Pathology Annual Meeting, Vancouver, BC, Canada [Abstract]. Mod Pathol, 25(suppl 2), 356A.

    Other

    1. Moser K (2016). Q&A: What is the value of doing incubated mixing studies on prolonged prothrombin times? CAP Today (30(6), p. 93).
    2. Moser K (2012). Diagnosis of heparin induced thrombocytopenia. NewsPath.
    3. Moser K (2011). Mixing studies: clinical utility and common points of confusion. College of American Pathologists 2011 CGL-C Proficiency Testing Educational Activity.
    4. Moser K, Eby CS (2010). Heparin induced thrombocytopenia. College of American Pathologists CGL-C Proficiency Testing Educational Activity.

  • News & Podcasts